 |
 |
|
David Altshuler, MD, PhD
Executive Vice President
Chief Scientific Officer
Vertex Pharmaceuticals
SAC 2019 through SAC 2023 (1st term)
|
Katrina Armstrong, MD
CEO, Columbia University Ivering Medical Center
Executive VP for Health and Biomedical Sciences,
Columbia University
Dean of Faculties of Health Sciences and the Vagelos College of Physicians and Surgeons
SAC 2023 through SAC 2027 (1st term)
|
 |
 |
|
Elazer R. Edelman, MD, PhD
Professor, Medical Engineering
and Science
Director, Institute for Medical
Engineering and Science (IMES)
Massachusetts Institute of Technology
SAC 2019 through SAC 2023 (1st term)
|
Mark C. Fishman, MD
Professor, Stem Cell and Regenerative Biology
Harvard University
Chief, Pathways Clinical Service
Massachusetts General Hospital
SAC 2021 through SAC 2025 (2nd term)
|
 |
 |
|
Elaine Fuchs, PhD
Investigator, Howard Hughes Medical Institute
Rebecca C. Lancefield Professor of Mammalian
Cell Biology and Development
The Rockefeller University
SAC 2023 through SAC 2027 (2nd term)
|
Talmadge E. King, Jr. MD
Dean, School of Medicine
Vice Chancellor, Medical Affairs
University of California, San Francisco
SAC 2019 through SAC 2023 (1st term)
|
 |
 |
Vivian S. Lee, MD, PhD, MBA
Executive Fellow, Senior Lecturer, Harvard Business School
SAC 2020 through SAC 2024 (2nd term) |
Daniel K. Podolsky, MD
President
University of Texas Southwestern Medical Center
SAC 2019 through SAC 2023 (2nd term)
|
 |
 |
Selwyn M. Vickers, MD, FACS
President and CEO,
Memorial Sloan Kettering Cancer Center
SAC 2019 through SAC 2023 (1st term) |
George Daley, MD, PhD
Dean, Faculty of Medicine Harvard
Medical School
Ex Officio |